Abera Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	175	125	69	75	62	173
Market Cap Growth	55.84%	81.17%	-7.22%	20.46%	-64.21%	-
Enterprise Value	149	102	66	73	49	159
Last Close Price	8.52	6.80	4.51	5.16	4.80	16.55
PS Ratio	14.76	10.59	4.73	29.57	34.66	146.97
PB Ratio	7.44	6.50	8.00	13.20	3.69	5.94
P/TBV Ratio	7.44	6.50	8.00	13.20	3.69	5.94
EV/Sales Ratio	12.56	8.63	4.52	28.83	27.67	135.29
Net Debt / Equity Ratio	-1.11	-1.22	-0.70	-0.59	-0.92	-0.41
Net Debt / EBITDA Ratio	1.60	2.25	4.77	-	-	-
Net Debt / FCF Ratio	2.47	6.38	4.58	0.19	0.78	1.24
Asset Turnover	0.55	0.56	1.27	0.18	0.07	0.07
Quick Ratio	3.63	2.64	1.36	1.11	5.80	5.51
Current Ratio	3.69	2.73	2.15	2.02	6.33	5.60
Return on Equity (ROE)	-101.15%	-74.82%	-15.37%	-149.06%	-84.39%	-61.97%
Return on Assets (ROA)	-48.16%	-31.46%	-7.29%	-73.14%	-47.73%	-33.40%
Return on Capital Employed (ROCE)	-70.00%	-55.00%	-15.50%	-299.20%	-115.90%	-31.50%
Earnings Yield	-9.31%	-8.33%	-1.59%	-22.40%	-31.28%	-5.29%
FCF Yield	-6.03%	-2.94%	-1.92%	-23.73%	-31.78%	-5.59%
Buyback Yield / Dilution	-33.52%	-5.59%	-18.42%	-13.66%	-14.64%	-45.39%